Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 14, Issue 28, Pages 4440-4444Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.14.4440
Keywords
Crohn's disease; Factor V Leiden; genetics; thrombosis; ulcerative colitis
Categories
Ask authors/readers for more resources
Thromboembolism is a significant cause of morbidity and mortality in patients with inflammatory bowel disease (IBD). Recent data suggest thromboembolism as a disease-specific extraintestinal manifestation of IBD, which is developed as the result of multiple interactions between acquired and genetic risk factors. There is evidence indicating an imbalance of procoagulant, anticoagulant and fibrinolitic factors predisposing in thrombosis in patients with IBD. The genetic factors that have been suggested to interfere in the thrombotic manifestations of IBD include factor V Leiden, factor U (prothrombin, G20210A), methylenetetrahydrofolate reductase gene mutation (MTHFR, 6777T), plasminogen activator inhibitor type 1 (PAI-1) gene mutation and factor X Ill (val34leu). In this article we review the current data and future prospects on the role of genetic risk factors in the development of thromboembolism in IBD. (C) 2008 The WJG Press. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available